R01 CA177681/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	6
2015	4
2016	4
2017	3
2019	2
2020	5
2021	3
2022	1
2025	0

1

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, Cho SH, Paik Y, Wang Q, Zhang S, Manning HC, Rathmell JC, Cook RS, Boothby MR, Chen J. Edwards DN, et al. J Clin Invest. 2021 Feb 15;131(4):e140100. doi: 10.1172/JCI140100. J Clin Invest. 2021. PMID: 33320840 Free PMC article.

2

Oncogenic functions and therapeutic targeting of EphA2 in cancer.

Wilson K, Shiuan E, Brantley-Sieders DM. Wilson K, et al. Oncogene. 2021 Apr;40(14):2483-2495. doi: 10.1038/s41388-021-01714-8. Epub 2021 Mar 8. Oncogene. 2021. PMID: 33686241 Free PMC article. Review.

3

Eph Receptor Tyrosine Kinases in Tumor Immunity.

Shiuan E, Chen J. Shiuan E, et al. Cancer Res. 2016 Nov 15;76(22):6452-6457. doi: 10.1158/0008-5472.CAN-16-1521. Epub 2016 Nov 3. Cancer Res. 2016. PMID: 27811149 Free PMC article. Review.

4

Eph receptor tyrosine kinases in cancer stem cells.

Chen J, Song W, Amato K. Chen J, et al. Cytokine Growth Factor Rev. 2015 Feb;26(1):1-6. doi: 10.1016/j.cytogfr.2014.05.001. Epub 2014 May 17. Cytokine Growth Factor Rev. 2015. PMID: 24933439 Free PMC article. Review.

5

Microenvironmental Metabolism Regulates Antitumor Immunity.

Ngwa VM, Edwards DN, Philip M, Chen J. Ngwa VM, et al. Cancer Res. 2019 Aug 15;79(16):4003-4008. doi: 10.1158/0008-5472.CAN-19-0617. Epub 2019 Jul 30. Cancer Res. 2019. PMID: 31362930 Free PMC article. Review.

6

Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer.

Song W, Kim LC, Han W, Hou Y, Edwards DN, Wang S, Blackwell TS, Cheng F, Brantley-Sieders DM, Chen J. Song W, et al. Mol Cancer Res. 2020 Nov;18(11):1735-1743. doi: 10.1158/1541-7786.MCR-20-0075. Epub 2020 Aug 4. Mol Cancer Res. 2020. PMID: 32753469 Free PMC article.

7

Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function.

Yang G, Song W, Postoak JL, Chen J, Martinez J, Zhang J, Wu L, Van Kaer L. Yang G, et al. Autophagy. 2021 May;17(5):1193-1204. doi: 10.1080/15548627.2020.1752979. Epub 2020 Apr 16. Autophagy. 2021. PMID: 32268825 Free PMC article.

8

Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity.

Wang S, Raybuck A, Shiuan E, Cho SH, Wang Q, Brantley-Sieders DM, Edwards D, Allaman MM, Nathan J, Wilson KT, DeNardo D, Zhang S, Cook R, Boothby M, Chen J. Wang S, et al. JCI Insight. 2020 Aug 6;5(15):e139237. doi: 10.1172/jci.insight.139237. JCI Insight. 2020. PMID: 32759497 Free PMC article.

9

mTORC1 and mTORC2 in cancer and the tumor microenvironment.

Kim LC, Cook RS, Chen J. Kim LC, et al. Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748764 Free PMC article. Review.

10

Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers.

Song W, Hwang Y, Youngblood VM, Cook RS, Balko JM, Chen J, Brantley-Sieders DM. Song W, et al. Oncogene. 2017 Oct 5;36(40):5620-5630. doi: 10.1038/onc.2017.170. Epub 2017 Jun 5. Oncogene. 2017. PMID: 28581527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year